Immune checkpoint inhibitors have transformed the treatment and prognosis of several advanced-stage cancers, but like any drug, they come with side effects. “As we expect increased use of these drugs ...
Safety outcomes of intravenous immunoglobulin (IVIG) in treatment of steroid-refractory immune-checkpoint inhibitor pneumonitis. A phase 1, first-in-human study of DS-2243, an HLA-A*02/NY-ESO–directed ...
Please provide your email address to receive an email when new articles are posted on . High-dose steroid use independently predicted hospital readmission for patients with immune checkpoint inhibitor ...
Please provide your email address to receive an email when new articles are posted on . More than 50% of adenomas developed within 7.5 months of immune checkpoint inhibitor-mediated diarrhea and ...
Chemotherapy and Supportive Care Practice Patterns Among Older Adults With Metastatic Pancreatic Cancer Patients with intestinal inflammatory diseases such as ulcerative colitis (UC), Crohn's disease ...
A recent case report highlights the fatal risks of pembrolizumab, an immune checkpoint inhibitor, after an 87-year-old patient developed severe immune-related adverse events. A case study from Kaiser ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results